7th Cachexia Conference演題募集中

7th International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)が、12月9-11日に神戸で開催されます。

http://www.lms-events.com/19/index.php

プログラムが上記HPに掲載されていました。また、抄録締め切りは9月10日で、10月末に採択の結果がわかるそうです。発表はポスターで発表1-2分、討議2-3分のようです。抄録が採択されると参加費が400ユーロに安くなりますので、出そうかどうか検討中です。

プログラム（仮）

Monday 9 December 2013
12:15-13:15
Lunch seminar(s)

13:30-15.30
A - OPENING SESSION: Muscle Wasting – Assessment & Epidemiology

Welcome: Akio Inui, Stefan Anker

1. “Hippocrates” clinical science key note lecture:
Assessing muscle mass – brief history and state of the art.
Stephen Heymsfield (Baton Rouge, LA / USA)
(30 min)

2. Muscle mass and survival: the epidemiologic viewpoint
Kam Kalantar-Zadeh (Los Angeles, CA / USA)
(18 min)

3. Psychosocial effect of cachexia
Jane Hopkinson (Cardiff / UK)
(18 min)

4. Frailty: international consensus and its role in sarcopenia and cachexia
John E Morley (St. Louis, MO / USA)
(18 min)

5. The obesity paradox in 2013 – the stroke example
Wolfram Doehner (Berlin / GER)
(18 min)

15:30-16:00
Coffee break

16:00-17:45
B - PLENARY SESSION: Muscle Wasting – New Therapeutic Approaches

6. “Prometheus” basic science key note lecture:
Ghrelin – from discovery to therapy.
Dr. Masayasu Kojima (Kurume / Japan)
(30 min)

7. Targeting MIC-1/GDF1
Samuel Breit (Sydney / AUS)
(18 min)

8. Parabiosis and muscle stem cell biology
(18 min)

9. Muscle regeneration & miRNAs
Thomas Thum (Hannover / DE)
(18 min)

10. Repair of traumatic muscle damage
Steve Badylak (Pittsburgh, PA / USA)
(18 min)

18:00-19:15
Welcome reception (poster area)


Tuesday 10 December 2013

7:15-8:15
Morning symposia

8:30-10:00
C - Clinical track: Skeletal muscle mass & chronic illness

11. New methods to assess skeletal muscle mass changes
William Evans (Research Triangle Park, NC / USA)
(18 min)

12. The interface between fat and muscle in late life sarcopenia & cachexia
Tamara Harris (Bethesda, MD / USA)
(18 min)

13. Cachexia in CHF and COPD: similarities and differences
Annemie Schols (Maastricht / NL)
(18 min)

14. Respiratory muscles mass and function & COPD exacerbation
Mike Polkey (London / UK)
(18 min)

15. Muscle wasting, exercise and hip fracture
Maria Fiatarone Singh (Sydney / Australia)
(18 min)

16. Biomarkers for skeletal muscle wasting – international consensus
Matteo Cesari (Toulouse / France)
(18 min)

8:30-10:00
D - Basic track: from food intake to ghrelin and sarcopenia

17. Alterations in the Ghrelin/NPY axis in anorexia and cachexia.
Herbert Herzog (Sydney / Australia)
(18 min)

18. Etanercept for cachexia in rheumatoid arthritis: roles of gut hormones and leptin.
Chih-Yen Chen (Taipei / Taiwan)
(18 min)

19. The herbal medicine rikkunshito in cancer anorexia-cachexia: impact on survival and relationship to ghrelin signaling.
Dr. Akihiro Asakawa (Kagoshima / Japan)
(18 min)

20. Modulation of hunger and satiety peptide activity by plasma immunoglobulins
Serguei Fetissov (Rouen / France)
(18 min)

21. Sarcopenic obesity
Dr. Kyung Mook Choi (Seoul / Korea)
(18 min)

10:00-11:00
Coffee break and poster session 1 (10:10-10:50, i.e. 10 posters x 4 min)

11:00-12:30
E - Basic track: Muscle basic science

22. GWAS in sarcopenia and cachexia research – state of affaires in 2013
David Glass (Basel / SUI) - invited
(15 min)

23. The mitochondrial contribution to muscle atrophy in aging and disease
(15 min)

24. Ca dynamic and RYR receptors
Osvaldo Delbono (Winston-Salem, NC / USA) - invited
(15 min)

25. Proteolysis mechanisms – an update
Didier Attaix (Clermont-Ferrand / France)
(15 min)

26. Muscle and non-muscle tissue interactions in cachexia: the role of inflammation.
Josep Argiles (Barcelona / ESP)
(15 min)

27. Panel discussion “Perspectives of research”
Chairs and speakers
(15 min)

11:00-12:30
F - Clinical track: Oncology and cancer cachexia – ASCO joint session (???)

28. Impact of cancer cachexia on oncology outcomes and anticancer treatment.
Florian Strasser (St. Gallen / SUI)
(18 min)

29. Multi-modal therapy for a multimodal problem: the MENAC study
Ken Fearon (Edinburgh / UK)
(18 min)

30. Diagnostic criteria of cancer cachexia: a critical evaluation
Vickie Baracos (Edmonton / CAN)
(18 min)

31. Cardiovascular problems and autonomic dysfunction in cancer cachexia.
Jochen Springer (Berlin / GER)
(18 min)

32. Nutritional intervention in cancer cachexia
Nicolaas Deutz (College Station, TX / USA)
(18 min)

12:45-13:45
Lunch seminar(s)

14:00-15:30
G - Clinical Track: Drug treatment options and results update

33. SARMs
(15 min)

34. Growth hormone + IGF-I
(15 min)

35. Ghrelin
(15 min)

36. Targeting myostatin & activin receptors
(15 min)

37. Novel beta-blockers
Stefan Anker (Berlin / GER)
(15 min)

38. Panel discussion
Chairs, experts and speakers
(15 min)

14:00-15:30
H - JUDGES’ CHOICE:
Rapid fire basic science (10-15 abstracts)
(rapid oral presentations (6-9 mins depending on number); to be chosen from the submitted abstracts – they highlight selected posters and focus on key results & messages)

Presentations will be selected from submitted abstracts.

15:30-16:30
Coffee break and poster session 2 (15:40-16:20, i.e. 10 posters x 4 min)

16:30-18:00
I - Clinical science track: Late breaking clinical trial and biomarker research
(to be chosen from the submitted abstracts and specific requests)

Presentations will be selected from submitted LBT abstracts.

16:30-18:00
K Basic track: Metabolic syndrome, biomarkers and body wasting

39. Cachexia in chronic kidney disease
Robert Mak (La Jolla, CA / USA)
(18 min)

40. Muscle wasting in diabetes
Antonio Zorzano (Barcelona / ESP)
(18 min)

41. Diabetes mellitus and muscle wasting
Seok Won Park (Seoul / Korea)
(18 min)

42. New biomarkers for skeletal muscle wasting in chronic illness
Stephan von Haehling (Berlin / GER)
(18 min)

43. Brown fat in cachexia
Graham Robertson (Concord / AUS)
(18 min)

19:30
Conference dinner


Wednesday 11 December 2011

8:00-9:30
L - Young investigators Award Session – Clinical & Basic
(Finalists: 3 abstracts clinical / 3 abstracts basic)

Presentations will be selected from submitted abstract.

8:00-9:30
M - Clinical & basic track: Food intake, appetite and nutrition

44. Effects of melatonin on appetite and other symptoms in cancer cachexia
Egidio Del Fabbro (Richmond, VA / USA)
(18 min)

45. Screening questionnaires for malnutrition and sarcopenia
Ted Malmstrom (St. Louis, MO / USA)
(18 min)

46. Mechanisms of anorexia
Johan Ruud (Linköping, Sweden)
(18 min)

47. Anorexia and quality of life.
Alessandro Laviano (Rome / ITA)
(18 min)

48. Nutrition in drug trials – problems & opportunities
Juergen Bauer (Nuremberg / Germany)
(18 min)

9:30-10:30
Coffee break and poster session 3 (9:40-10:20, i.e. 10 x 4 min)

10:30-12:00
N - JUDGES’ CHOICE: Rapid fire clinical & nutrition science (10-15 abstracts)
(rapid oral presentations (6-9 mins depending on number); to be chosen from the submitted abstracts – they highlight selected posters and focus on key results & messages)

Remote monitoring of body weight, fluid status and physical activity: telemedicine for cachexia & sarcopenia?!
Friedrich Koehler (Berlin / Germany)

Presentations will be selected from submitted abstracts.

10:30-12:00
O - Basic track: Central mechanisms of cachexia

49. Rodent models of cachexia: predict power for clinical trials
Daniel Marks (Portland, OR / USA)
(18 min)

50. The role of the brain stem: autonomic dysfunction
Massimo Piepoli (Piacenza / ITA)
(18 min)

51. Central mechanisms of fatigue
(18 min)

52. Abnormal reflex systems in cachexia
Ewa Jankowska (Wroclaw / POL)
(18 min)

53. CNS contribution to muscle atrophy and the plasticity of motor units.
(18 min)

12:15-13:15
Lunch seminar(s)

13:30-15:00
P - PLENARY SESSION: Developing therapies for cachexia & sarcopenia

54. The role of blood based biomarkers for muscle wasting treatment trials
Marc Hellerstein (Berkeley, CA / USA) - invited
(15 min)

55. Why are so many companies studying inclusion body myositis?
(15 min)

56. What should usual care for nutrition be in cachexia trials?
Aminah Jatoi (Rochester, MI / USA)
(15 min)

57. What are approvable endpoints in cachexia & sarcopenia?
Stefan Anker (Berlin / GER)
(15 min)

58. The regulators comments – 1
Representative from FDA or EMA
(5 min)

59. The regulators comments - 2
Representative from regulators in Asia
(5 min)

60. Pannel discussion
Chairs, speaker, experts
(20 min)

15:00-15:30
Coffee break

15:30-16:30
Q - PLENARY SESSION: Highlights

Chaired by: V Baracos
K Kalantar-Zadeh

61. Basic Science
Denis Guttridge (Columbus, OH / USA)
(15 min)

62. Sarcopenia
Mitja Lainscak (Golnik / Slovenia)
(15 min)

63. Nutritional Therapies
Maurizio Muscaritoli (Rome / ITA) - invited
(15 min)

64. Treatment of cachexia
Andrew Coats (Melbourne / Australia)
(15 min)

Awards Ceremony
Poster Award